April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
Wall Street Lunch: Big Tech Bearishness?
Apple Should Climb The Wall Of Worry
Microsoft Q3 Preview: Focusing On Copilot
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Regeneron Pharmaceuticals (REGN) Stock Forecast for 2024–2028. Sell or Buy?
Updated: April 23, 2024 (05:51)
Sector: HealthcareThe share price of Regeneron Pharmaceuticals, Inc. (REGN) now
50/200 Day Moving Average: $952.79 / $859.22
This figure corresponds to the Average Price over the previous 50/200 days. For Regeneron Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For Regeneron Pharmaceuticals stocks, the 200-day moving average is the support level today.
Are you interested in Regeneron Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Regeneron Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Regeneron Pharmaceuticals share be worth in 2024 - 2028?
When should I take profit in Regeneron Pharmaceuticals stock? When should I record a loss on Regeneron Pharmaceuticals stock? What are analysts' forecasts for Regeneron Pharmaceuticals stock? What is the future of Regeneron Pharmaceuticals stock? We forecast Regeneron Pharmaceuticals stock performance using neural networks based on historical data on Regeneron Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Regeneron Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Regeneron Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Regeneron Pharmaceuticals stock
The chart below shows the historical price of Regeneron Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Regeneron Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Regeneron Pharmaceuticals, Inc. is an American biotech company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Initially, it focused on neurotrophic factors and their regenerative capabilities (hence the name), and then branched out into the study of both cytokine and tyrosine kinase receptors.
Regeneron Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr 25 | 937.98 | 924.17 | 955.99 | 3.44 |
| Apr 26 | 935.88 | 915.52 | 946.06 | 3.34 |
| Apr 27 | 924.50 | 901.13 | 932.78 | 3.51 |
| Apr 28 | 930.71 | 922.08 | 948.88 | 2.91 |
| Apr 29 | 923.56 | 915.58 | 931.84 | 1.78 |
| Apr 30 | 935.09 | 916.24 | 958.43 | 4.60 |
| May 01 | 950.05 | 940.02 | 959.17 | 2.04 |
| May 02 | 950.96 | 927.84 | 959.48 | 3.41 |
| May 03 | 972.57 | 955.45 | 984.40 | 3.03 |
| May 04 | 986.57 | 969.84 | 1 002.04 | 3.32 |
| May 05 | 963.84 | 953.36 | 980.50 | 2.85 |
| May 06 | 963.54 | 942.88 | 985.74 | 4.55 |
| May 07 | 985.43 | 972.81 | 995.83 | 2.37 |
| May 08 | 991.10 | 984.44 | 1 000.30 | 1.61 |
| May 09 | 981.59 | 971.54 | 996.04 | 2.52 |
| May 10 | 986.61 | 971.78 | 998.61 | 2.76 |
| May 11 | 1 002.08 | 989.26 | 1 012.02 | 2.30 |
| May 12 | 1 000.80 | 993.44 | 1 022.58 | 2.93 |
| May 13 | 988.95 | 972.81 | 1 004.78 | 3.29 |
| May 14 | 963.32 | 943.59 | 983.66 | 4.25 |
| May 15 | 955.61 | 937.57 | 962.65 | 2.67 |
| May 16 | 950.11 | 930.95 | 958.32 | 2.94 |
| May 17 | 970.48 | 953.71 | 980.42 | 2.80 |
| May 18 | 976.69 | 963.88 | 997.00 | 3.44 |
| May 19 | 1 003.88 | 978.50 | 1 017.05 | 3.94 |
| May 20 | 1 024.76 | 1 016.56 | 1 035.25 | 1.84 |
| May 21 | 1 008.69 | 1 002.24 | 1 019.99 | 1.77 |
| May 22 | 1 007.72 | 1 000.95 | 1 027.72 | 2.67 |
| May 23 | 1 015.46 | 999.22 | 1 039.18 | 4.00 |
| May 24 | 1 026.51 | 1 003.52 | 1 049.51 | 4.58 |
Regeneron Pharmaceuticals Daily Price Targets
Regeneron Pharmaceuticals Stock Forecast 04-25-2024.
Forecast target price for 04-25-2024: $937.98.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.328%.
Pessimistic target level: 924.17
Optimistic target level: 955.99
Regeneron Pharmaceuticals Stock Forecast 04-26-2024.
Forecast target price for 04-26-2024: $935.88.
Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.229%.
Pessimistic target level: 915.52
Optimistic target level: 946.06
Regeneron Pharmaceuticals Stock Forecast 04-27-2024.
Forecast target price for 04-27-2024: $924.50.
Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.394%.
Pessimistic target level: 901.13
Optimistic target level: 932.78
Regeneron Pharmaceuticals Stock Forecast 04-28-2024.
Forecast target price for 04-28-2024: $930.71.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 2.825%.
Pessimistic target level: 922.08
Optimistic target level: 948.88
Regeneron Pharmaceuticals Stock Forecast 04-29-2024.
Forecast target price for 04-29-2024: $923.56.
Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 1.744%.
Pessimistic target level: 915.58
Optimistic target level: 931.84
Regeneron Pharmaceuticals Stock Forecast 04-30-2024.
Forecast target price for 04-30-2024: $935.09.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 4.402%.
Pessimistic target level: 916.24
Optimistic target level: 958.43
REGN (REGN) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 969.46 | 944.16 | 1 026.18 | 7.99 |
| Jun. | 977.32 | 912.23 | 1 007.22 | 9.43 |
| Jul. | 947.41 | 924.39 | 991.75 | 6.79 |
| Aug. | 886.02 | 861.30 | 929.08 | 7.30 |
| Sep. | 913.13 | 890.12 | 957.51 | 7.04 |
| Oct. | 895.87 | 864.43 | 940.22 | 8.06 |
| Nov. | 918.45 | 880.42 | 949.86 | 7.31 |
| Dec. | 930.85 | 912.42 | 987.81 | 7.63 |
Regeneron Pharmaceuticals forecast for this year
Regeneron Pharmaceuticals Stock Prediction for May 2024
An uptrend is forecast for this month with an optimal target price of $969.462. Pessimistic: $944.16. Optimistic: $1 026.18
Regeneron Pharmaceuticals Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $977.315. Pessimistic: $912.23. Optimistic: $1 007.22
Regeneron Pharmaceuticals Stock Prediction for Jul 2024
An downtrend is forecast for this month with an optimal target price of $947.409. Pessimistic: $924.39. Optimistic: $991.75
Regeneron Pharmaceuticals Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $886.017. Pessimistic: $861.30. Optimistic: $929.08
Regeneron Pharmaceuticals Stock Prediction for Sep 2024
An uptrend is forecast for this month with an optimal target price of $913.129. Pessimistic: $890.12. Optimistic: $957.51
Regeneron Pharmaceuticals Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $895.871. Pessimistic: $864.43. Optimistic: $940.22
Regeneron Pharmaceuticals Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $918.447. Pessimistic: $880.42. Optimistic: $949.86
Regeneron Pharmaceuticals Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $930.846. Pessimistic: $912.42. Optimistic: $987.81
Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 940.90 | 890.94 | 975.62 | 8.68 |
| Feb | 1 007.80 | 939.77 | 1 036.82 | 9.36 |
| Mar | 978.77 | 933.85 | 1 043.96 | 10.55 |
| Apr | 934.73 | 887.62 | 961.65 | 7.70 |
| May | 953.24 | 887.18 | 980.69 | 9.54 |
| Jun | 925.78 | 891.62 | 981.61 | 9.17 |
| Jul | 964.11 | 940.68 | 995.35 | 5.49 |
| Aug | 1 008.36 | 987.49 | 1 030.14 | 4.14 |
| Sep | 971.15 | 952.80 | 1 030.59 | 7.55 |
| Oct | 973.78 | 935.21 | 1 022.85 | 8.57 |
| Nov | 1 001.82 | 974.77 | 1 062.23 | 8.23 |
| Dec | 947.72 | 920.43 | 1 000.61 | 8.01 |
Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 874.37 | 818.50 | 897.19 | 8.77 |
| Feb | 902.70 | 837.70 | 936.82 | 10.58 |
| Mar | 935.20 | 900.69 | 953.71 | 5.56 |
| Apr | 949.50 | 898.23 | 1 012.74 | 11.31 |
| May | 970.01 | 933.35 | 999.70 | 6.64 |
| Jun | 1 007.55 | 986.70 | 1 044.73 | 5.55 |
| Jul | 1 096.42 | 1 066.82 | 1 133.92 | 5.92 |
| Aug | 1 120.10 | 1 063.65 | 1 175.55 | 9.52 |
| Sep | 1 027.36 | 993.15 | 1 054.17 | 5.79 |
| Oct | 994.07 | 940.39 | 1 012.86 | 7.15 |
| Nov | 990.49 | 952.16 | 1 046.65 | 9.03 |
| Dec | 1 036.85 | 996.72 | 1 080.71 | 7.77 |
Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1 009.79 | 976.16 | 1 061.59 | 8.05 |
| Feb | 995.24 | 949.56 | 1 018.53 | 6.77 |
| Mar | 988.97 | 930.23 | 1 038.82 | 10.45 |
| Apr | 982.74 | 919.06 | 1 037.58 | 11.42 |
| May | 960.63 | 932.97 | 1 003.86 | 7.06 |
| Jun | 978.79 | 926.81 | 999.93 | 7.31 |
| Jul | 937.39 | 904.48 | 955.95 | 5.38 |
| Aug | 897.73 | 865.42 | 940.56 | 7.99 |
| Sep | 887.23 | 868.87 | 928.75 | 6.45 |
| Oct | 875.25 | 826.41 | 925.67 | 10.72 |
| Nov | 861.86 | 841.69 | 903.75 | 6.87 |
| Dec | 842.47 | 815.17 | 868.25 | 6.11 |
Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 868.25 | 806.52 | 916.70 | 12.02 |
| Feb | 880.75 | 840.33 | 927.52 | 9.40 |
| Mar | 910.87 | 885.46 | 974.00 | 9.09 |
| Apr | 986.29 | 950.79 | 1 036.89 | 8.30 |
| May | 991.62 | 950.57 | 1 054.09 | 9.82 |
| Jun | 986.27 | 940.11 | 1 012.89 | 7.19 |
| Jul | 1 029.76 | 971.37 | 1 052.93 | 7.75 |
| Aug | 1 045.51 | 976.82 | 1 117.97 | 12.63 |
| Sep | 1 011.64 | 940.62 | 1 059.90 | 11.25 |
| Oct | 957.01 | 910.50 | 990.60 | 8.09 |
| Nov | 963.04 | 904.10 | 1 020.25 | 11.38 |
| Dec | 981.24 | 912.36 | 1 007.74 | 9.46 |
Regeneron Pharmaceuticals information and performance
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US
Market capitalization of the Regeneron Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of REGN shares in the company outstanding by the market price of one share.
EBITDA of Regeneron Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
